Search Browse Earnings

Estrella Immunopharma, Inc. — SlamSEC

Estrella Immunopharma, Inc.

Nasdaq:ESLANasdaq:ESLAW

Biological Products, (No Diagnostic Substances)·EMERYVILLE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

-$11.1M

FY 2024

EPS (Diluted)

-$36.35

FY 2024

Stock Price

$1.12

+4.7%

2026-03-09

52W Range

$0.73 – $3.15

P/E Ratio

-0.0x

Market Cap

$42.3M

Cash

$2.5M

FY 2024

Total Debt

—

Net Cash

$2.5M

Enterprise Value

$39.8M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Liu Cheng

CFO

Xu Jiandong